The Supreme Court has issued a temporary pause on a lower court ruling that could have substantially restricted access to abortion medication across the United States. This emergency stay ensures that the abortion pill, particularly Mifepristone—one of the main drugs used in medication abortions—remains accessible, often through mail delivery, while further legal review takes place.
Legal scholar Mary Ziegler from the University of California, Davis School of Law, discusses the significance of this provisional decision and considers the potential future directions for abortion access in the country. The temporary measure highlights ongoing judicial debates surrounding reproductive rights and the availability of medication abortions nationwide.